Generation of functional ciliated cholangiocytes from human pluripotent stem cells

Area of Science:

• Stem cell biology
• Hepatology
• Regenerative medicine

Background:

• Cholangiopathies are liver diseases affecting bile ducts.
• Current methods for deriving cholangiocytes from human pluripotent stem cells (hPSCs) are inefficient and yield immature cells.
• Immature cholangiocytes limit their use in disease modeling and therapeutic development.

Purpose of the Study:

• To generate fully mature, functional cholangiocytes from hPSCs.
• To establish a reliable model for studying cholangiopathies.
• To explore therapeutic applications for biliary diseases.

Main Methods:

• Utilized advanced differentiation protocols to derive cholangiocytes from hPSCs.
• Characterized the derived cholangiocytes for maturity markers, including cystic fibrosis transmembrane conductance regulator (CFTR) expression and primary cilia presence.
• Assessed the functionality of hPSC-derived cholangiocytes in vitro and in vivo transplantation models.

Main Results:

• Successfully generated functional cholangiocytes from hPSCs with characteristics of mature bile duct cells.
• The derived cells exhibited high levels of CFTR and functional primary cilia.
• Transplantation of these mature cholangiocytes into immunocompromised mice resulted in the formation of ductal structures in the liver.

Conclusions:

• Mature hPSC-derived cholangiocytes represent a significant advancement for modeling cholangiopathies and testing therapies, such as cystic fibrosis drugs.
• These cells hold potential for cell-based therapies aimed at restoring bile duct function in patients with biliary diseases.
• The study highlights the importance of cellular maturity for therapeutic applications in regenerative medicine.